Clinical Practice Session
New Insights into Achieving Meaningful Weight Loss in CKD, Including the Burton D. Rose, MD, Endowed Lectureship
November 03, 2023 | 10:30 AM - 12:30 PM
Location: Room 108, Pennsylvania Convention Center
Session Description
A leading cause of CKD is poor metabolic health due to high-carbohydrate diets and lifestyles that lead to chronically elevated blood glucose and obesity. Given the obesity epidemic and its implications for kidney health, the nephrologist needs to be aware of novel mechanisms and ways to achieve meaningful weight loss. This session addresses several different mechanisms to achieve weight loss in patients with CKD.
ASN gratefully acknowledges Wolters Kluwer (publisher of UpToDate), the Beth Israel Deaconess Medical Center Department of Medicine Foundation, the Rose Family, and several of Dr. Rose's colleagues for supporting this lectureship.
Learning Objective(s)
- Explain dietary intervention programs to implement ketogenic metabolic therapies
- Discuss the mechanism by hypobaric hypoxia leads to weight loss and decreased appetite, include nonshivering thermogenesis
- Summarize pharmacologic mechanisms of weight loss, including SGLT2 inhibitors and GLP1 agonists
- Identify mechanisms of weight loss with gastric bypass in CKD patients
Learning Pathway(s)
- CKD Non-Dialysis
Moderators
Presentations
- Hypobaric Hypoxia and Its Cardiorenal Benefit for Weight Loss: The Burton D. Rose, MD, Endowed Lectureship
10:30 AM - 11:00 AM
- Ketogenic Metabolic Therapies for CKD
11:00 AM - 11:30 AM
- Bariatric Surgery: Mechanism and Efficacy in CKD
11:30 AM - 12:00 PM
- Pharmacologic Mechanisms of Weight Loss to Include SGLT2 Inhibitors and GLP1/GIP Agonists
12:00 PM - 12:30 PM